Lapatinib and Trastuzumab With or Without Endocrine Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Lapatinib|DRUG: Trastuzumab|DRUG: Endocrine
Sponsor: Baylor Breast Care Center
Collaborators: GlaxoSmithKline